Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium
Ronald Goldberg, Vanita R. Aroda, David A. Bluemke, et al.
Circulation (2017) Vol. 136, Iss. 1, pp. 52-64
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Metformin as a Tool to Target Aging
Nir Barzilai, Jill P. Crandall, Stephen B. Kritchevsky, et al.
Cell Metabolism (2016) Vol. 23, Iss. 6, pp. 1060-1065
Open Access | Times Cited: 872
Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway
Huiwen Ren, Ying Shao, Can Wu, et al.
Molecular and Cellular Endocrinology (2019) Vol. 500, pp. 110628-110628
Closed Access | Times Cited: 253
Prediabetes and What It Means: The Epidemiological Evidence
Justin B. Echouffo‐Tcheugui, Elizabeth Selvin
Annual Review of Public Health (2020) Vol. 42, Iss. 1, pp. 59-77
Open Access | Times Cited: 233
Diagnosis and Management of Prediabetes
Justin B. Echouffo‐Tcheugui, Leigh Perreault, Linong Ji, et al.
JAMA (2023) Vol. 329, Iss. 14, pp. 1206-1206
Closed Access | Times Cited: 217
Sex- and Gender-Based Pharmacological Response to Drugs
Franck Mauvais‐Jarvis, Heiner K. Berthold, Ilaria Campesi, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 730-762
Open Access | Times Cited: 135
Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms
Sheng Chen, Donghao Gan, Sixiong Lin, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2722-2740
Open Access | Times Cited: 114
Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study
Ronald Goldberg, Trevor J. Orchard, Jill P. Crandall, et al.
Circulation (2022) Vol. 145, Iss. 22, pp. 1632-1641
Open Access | Times Cited: 104
Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis, Niyoti Reddy, Chrysoula Boutari, et al.
Metabolism (2022) Vol. 137, pp. 155332-155332
Closed Access | Times Cited: 98
Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification
Nadia R. Sutton, Rajeev Malhotra, Cynthia St. Hilaire, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 43, Iss. 1, pp. 15-29
Open Access | Times Cited: 73
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
Vanita R. Aroda, William C. Knowler, Jill P. Crandall, et al.
Diabetologia (2017) Vol. 60, Iss. 9, pp. 1601-1611
Open Access | Times Cited: 170
Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation
Wenting Fang, Jing Zhang, Luyan Hong, et al.
Journal of Affective Disorders (2019) Vol. 260, pp. 302-313
Closed Access | Times Cited: 121
Impact of advanced glycation end products (AGEs) signaling in coronary artery disease
Marinos Kosmopoulos, Dimitrios Drekolias, Phaedon D. Zavras, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 3, pp. 611-619
Closed Access | Times Cited: 103
Metformin, Macrophage Dysfunction and Atherosclerosis
Xiaojun Feng, Wenxu Chen, Xiayun Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93
Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
Mojca Lunder, Miodrag Janić, M. Japelj, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 84
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction
Brian A. Bergmark, Deepak L. Bhatt, Darren K. McGuire, et al.
Circulation (2019) Vol. 140, Iss. 12, pp. 1004-1014
Open Access | Times Cited: 78
Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK‐dependent mechanisms
Yizhi Bu, Mei Peng, Xinyi Tang, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 19, pp. 4886-4903
Open Access | Times Cited: 50
Cardiovascular Protection by Metformin: Latest Advances in Basic and Clinical Research
Jason Li, Y Robert Li
Cardiology (2023) Vol. 148, Iss. 4, pp. 374-384
Closed Access | Times Cited: 24
Interventions to promote cardiometabolic health and slow cardiovascular ageing
Luigi Fontana
Nature Reviews Cardiology (2018) Vol. 15, Iss. 9, pp. 566-577
Closed Access | Times Cited: 82
Restoring mitochondrial biogenesis with metformin attenuates β-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4/oxidative stress-mediated apoptosis
Wenqi Ma, Xuejiao Sun, Ying Wang, et al.
Molecular and Cellular Endocrinology (2018) Vol. 479, pp. 39-53
Closed Access | Times Cited: 82
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
David M. Nathan, Peter H. Bennett, Jill P. Crandall, et al.
Diabetologia (2019) Vol. 62, Iss. 8, pp. 1319-1328
Open Access | Times Cited: 74
Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
Leigh Perreault, Qing Pan, Emily B. Schroeder, et al.
Diabetes Care (2019) Vol. 42, Iss. 9, pp. 1809-1815
Open Access | Times Cited: 73
Obesity and Erectile Dysfunction: From Bench to Clinical Implication
Ki Hak Moon, So‐Young Park, Yong-Woon Kim
The World Journal of Men s Health (2018) Vol. 37, Iss. 2, pp. 138-138
Open Access | Times Cited: 61
The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes
Matthew J. Budoff, Jye‐Yu C. Backlund, David A. Bluemke, et al.
JACC. Cardiovascular imaging (2019) Vol. 12, Iss. 7, pp. 1341-1349
Open Access | Times Cited: 61
Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
Kasper Madsen, Yuan Chi, Maria‐Inti Metzendorf, et al.
Cochrane library (2019) Vol. 2019, Iss. 12
Open Access | Times Cited: 56
Metformin for diabetes prevention: update of the evidence base
Ulrike Hostalek, Ian W. Campbell
Current Medical Research and Opinion (2021) Vol. 37, Iss. 10, pp. 1705-1717
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top